✦ LIBER ✦

Clinical study with bleomycin: Tolerance to twice weekly dosage

✍ Scribed by Takao Ohnuma; Oleg S. Selawry; James F. Holland; Vincent T. DeVita Jr.; Donald P. Shedd; Heine H. Hansen; Franco M. Muggia

Book ID: 102666256
Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 635 KB
Volume: 30
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197210)30:4<914::aid-cncr2820300409>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind study to determine the ma

A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis

✍ S. Devadatta; N.K. Menon; O. Nazareth; S. Radhakrishna; C.V. Ramakrishnan; P.R. 📂 Article 📅 1970 🏛 Elsevier Science 🌐 English ⚖ 609 KB

Dosage frequency and drug-compliance beh

Dosage frequency and drug-compliance behaviour — a comparative study on compliance with a medication to be taken twice or four times daily

✍ W. Kruse; W. Eggert-Kruse; J. Rampmaier; B. Runnebaum; E. Weber 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 440 KB

The objective of the study was to investigate patient compliance with two different dosage regimens. Ethinyloestradiol 80 micrograms daily was prescribed to 35 female outpatients to be taken as 20 micrograms four times daily or 40 micrograms twice daily for 7 days. It was given to standardise cervic

Reduction of relapses of atopic dermatit

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

✍ A. Peserico; G. Städtler; M. Sebastian; R. Suarez Fernandez; K. Vick; T. Bieber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Phase I study of the heat shock protein

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

✍ Lancet, J E; Gojo, I; Burton, M; Quinn, M; Tighe, S M; Kersey, K; Zhong, Z; Albi 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 337 KB

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 128 KB

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad